Pioglitazone Prevents the Increase in Plasma Ketone Concentration Associated with Dapagliflozin in Insulin ‐Treated T2DM Patients: Results from the Qatar Study

Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-.

Source: Diabetes, Obesity and Metabolism - September 27, 2018 Category: Endocrinology Authors: Muhammad Abdul ‐Ghani, Osama Migahid, Ayman Megahed, Rajvir Singh, Mohammad Fawaz, Ralph A. DeFronzo, Amin Jayyousi Source Type: research